Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Research and development	6,341	19,178	23,455	82,684
General and administrative	11,547	19,088	32,649	66,840
Product manufacturing	8,115		15,688
Total operating expenses	26,003	38,266	71,792	149,524
Loss from operations	(26,003)	(38,266)	(71,792)	(149,524)
Other income	67	7,898	1,470	1,638
Loss on extinguishment of debt	(1,049)		(1,049)
Interest expense on note payable to principal stockholder	(729)	(729)	(2,164)	(2,164)
Interest expense on notes	(4,145)	(5,424)	(17,899)	(11,895)
Interest income	2	1	8	4
Loss before benefit for income taxes	(31,857)	(36,520)	(91,426)	(161,941)
Income tax benefit	0	0	0	0
Net loss	$ (31,857)	$ (36,520)	$ (91,426)	$ (161,941)
Net loss per share - basic and diluted	$ (0.08)	$ (0.09)	$ (0.23)	$ (0.42)
Shares used to compute basic and diluted net loss per share	405,199	394,163	401,734	381,332

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

No definition available.